Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT01335360
Eligibility Criteria:
Inclusion criteria:
1. Documented HIV infection
2. 18-50yrs of age
3. Male
4. Currently on nevirapine therapy for at least 3 months
5. LFT's \< 2 times normal limits within one month prior to study date
6. In good health as judged by their primary care provider or a study provider within one month of the study date
7. Willing to abstain for 1 week prior to study date
8. No active opportunistic infections within one month prior to the study date
9. Willingness to sign informed consent
Exclusion criteria:
1. Active substance abuse
2. Poor self reported adherence to nevirapine therapy
3. Chronic liver disease or active hepatitis
4. Concurrent administration of medications with a known or suspected pharmacokinetic drug interaction with nevirapine (such as …)
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT01335360
Study Brief:
Protocol Section:
NCT01335360